ASX Company Webcasts
Xsights Webcast Replay
In this session Steve Wildisen presents Xsights’ global scaling strategy and near-term exit plans, as they look to execute on their ~$940m pipeline with one of these contracts alone being a potential company-maker.
Xsights Q&A Replay
In this session Steve Wildisen discusses the commercialisation and the speed of adoption of Xsight’s technology by the world’s largest industry operators and who the potential acquirers of Xsights are as they aim for a $1bn+ exit.
Prescient Therapeutics (ASX: PTX) Webcast Replay
In this session Prescient CEO James McDonnell discusses the outstanding PTX-100 Phase 1b results including the 64% tumor halt or reduction for a cancer considered a ‘death sentence’.
Felix Gold (ASX: FXG) Webcast Replay
In this session Felix Gold Executive Director Joseph Webb discussed why the company holds what we believe to be the premier antimony asset in the United States.
Felix Gold (ASX: FXG) Webcast Replay
In this session Felix Gold Executive Director Joseph Webb discussed why the company holds what we believe to be the premier antimony asset in the United States.
Prescient Therapeutics (ASX: PTX) Webcast Replay
In this session Prescient CEO James McDonnell discusses why the First Patient Dosed marks a significant milestone in the commencement of the PTX-100 Phase 2a study, bringing a potential treatment one step closer to a current unmet need.
MDF Global Q&A Update
In this session MDF Global Managing Director Joe Webb discussed their plans to become possibly the largest exploration company on the planet within 5 years.
MDF Global Q&A Update
In this session MDF Global Managing Director Joe Webb discussed their plans to become possibly the largest exploration company on the planet within 5 years.
MDF Global Shareholder Webcast Replay
In this session MDF Global Managinf Director Joseph Webb discussed the company’s plans to become possibly the largest exploration company on the planet within 5 years.
Felix Gold (ASX: FXG) Webcast Replay
In this session Felix Gold Executive Director Joseph Webb discussed why the company holds what we believe to be the premier antimony asset in the United States.
Prescient Therapeutics Webcast Replay
In this session Prescient Therapeutics (ASX: PTX) CEO James McDonnell provides investors with a company update.
Xsights Q&A Update
In this session Xsights Co-Founder and CEO Steve Wildisen provides investors with a company update.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.